The role of menopausal hormone therapy in women with or at risk of ovarian and breast cancers: Misconceptions and current directions-Reference-Cited by-同舟云学术

The role of menopausal hormone therapy in women with or at risk of ovarian and breast cancers: Misconceptions and current directions

Published:2018-12-20 Issue:4 Volume:125 Page:499-514
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Temkin Sarah M.¹,Mallen Adrianne²,Bellavance Emily³,Rubinsak Lisa¹,Wenham Robert M.²

Affiliation:

1. Department of Obstetrics and Gynecology, Division of Gynecologic Oncology Virginia Commonwealth University Richmond Virginia

2. Department of Gynecologic Oncology Moffitt Cancer Center Tampa Florida

3. Department of Surgery, Division of General and Oncologic Surgery University of Maryland Baltimore Maryland

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.31911

Reference152 articles.

1. Cancer statistics, 2018

2. National Cancer Institute Surveillance Epidemiology and End Results Program.Cancer stat facts: ovarian cancer.http://seer.cancer.gov/statfacts/html/ovary.html. Accessed May 16 2018.

3. Real-world evidence in the treatment of ovarian cancer

4. 2009 Wolters Kluwer Health/Lippincott Williams & Wilkins Philadelphia PA RR Barakat M Markman M Randall Principles and Practice of Gynecologic Oncology

5. Estrogen Carcinogenesis in Breast Cancer

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and safety of menopause treatments: pitfalls of available evidence and future research need;Climacteric;2024-01-26

2. Efficacy of a Diode Vaginal Laser in the Treatment of the Genitourinary Syndrome of Menopause;Bioengineering;2023-10-02

3. Effect of Self-Rated Work Burden, Family History and HRT on Postmenopausal Breast Cancer Risk – Population Based 25-Year Follow-Up Study;2023

4. The Prevalence of Dietary Supplements That Claim Estrogen-like Effects in Japanese Women;Nutrients;2022-10-26

5. Clinical and molecular evaluation of patients with ovarian cancer in the context of drug resistance to chemotherapy;Frontiers in Oncology;2022-08-05